Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio G De Angelis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Tumori|February 10, 2011
Imaging techniques in diagnostic approachesClaudio G De Angelis, Flavio Crippa
Global & Regional Health Technology Assessment|January 17, 2025
The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in ItalyPaolo Sciattella, Annarosa Fornero, Susanna M A Giordano, et al.
Minerva Gastroenterology|April 1, 2021
Training in advanced bilio-pancreatic endoscopyClaudio G DE Angelis, Stefano Rizza, Felice Rizzi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Tumori|February 10, 2011
Imaging techniques in diagnostic approachesClaudio G De Angelis, Flavio Crippa
Global & Regional Health Technology Assessment|January 17, 2025
The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in ItalyPaolo Sciattella, Annarosa Fornero, Susanna M A Giordano, et al.
Minerva Gastroenterology|April 1, 2021
Training in advanced bilio-pancreatic endoscopyClaudio G DE Angelis, Stefano Rizza, Felice Rizzi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Pageof 1